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Background 
Non-adherence to medicines for long-term conditions is a complex, prevalent 
phenomenon, with significant clinical and economic consequences for patients 
and health providers worldwide.  
Objectives 
To test the effectiveness of a pharmacist-led intervention to improve adherence, 
in the context of mail-order pharmacy. 
Methods 
A parallel-group RCT was conducted. 677 patients prescribed at least one oral 
medication for type 2 diabetes and/or lipid regulation were recruited from a UK 
mail-order pharmacy between Nov 2012-Sept 2013, and randomised (340 
intervention, 337 control). The intervention was patient-centred, comprising 
information and advice by phone and written information by post, delivered by a 
pharmacist. All elements of the intervention were tailored to the individuals’ 
needs. The primary outcome was self-reported adherence to medication at 6-
month follow-up, measured using the Diagnostic Adherence to Medication Scale. 
Generalised estimating equations analyses were conducted according to the 
intention-to-treat principle. Secondary outcomes included prescription refill 
adherence defined as a medication possession ratio and lipid and glycemic 
control. 
Results 
Patients who received the intervention had 54% increased odds of being 
adherent (defined as ≥90% of medication taken in the past 7 days), compared 
with the control group (OR 1.54, 95%CI 1.11-2.15, p=0.01). Analyses of 
dispensing data also showed that the odds of being classified as adherent 
(≥90%) were 60% greater for the intervention group compared with the control 
group (OR 1.60, 95%CI 1.14-2.24, p<0.01). For patients who provided a blood 
sample at 6-month follow up, 67% vs 31% (16 intervention, 5 control, p=0.06) 
and 65% vs 55% (64 intervention, 38 control, p=0.24) achieved guideline targets 
for glycemic and lipid control, respectively. 
Conclusions 
Intervention, led by a pharmacist and tailored to the individuals’ needs, can 
significantly improve medication adherence in patients with long-term 
conditions. The findings provide further support for the enhanced role of 
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pharmacists in supporting and advising patients with their medicines, and 
improving outcomes. 
 
